embecta to Participate at the 2026 BofA Securities Global Health Care Conference
Rhea-AI Summary
Embecta (Nasdaq: EMBC) will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET. Audio webcasts will be available via the News & Events section of the company's investor relations site at investors.embecta.com.
Positive
- None.
Negative
- None.
News Market Reaction – EMBC
In the May 8 session, EMBC gained 1.11%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 05 | Dividend announcement | Negative | -57.8% | Quarterly cash dividend declared following broader capital allocation changes. |
| May 05 | Earnings results | Negative | -57.8% | Second quarter fiscal 2026 results and webcast details released. |
| Apr 21 | Earnings date set | Neutral | +2.1% | Announcement of timing and access details for Q2 2026 results call. |
| Mar 19 | Acquisition deal | Positive | +2.9% | Agreement to acquire Owen Mumford to expand drug-delivery platforms. |
| Feb 11 | Leadership change | Neutral | -0.6% | New chairman and lead independent director appointed after prior chair’s retirement. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with negative fundamentals (weak Q2, dividend cut, guidance reduction) coincided with a sharp selloff, while strategic moves like the Owen Mumford acquisition saw modest positive reactions.
Over the last six months, Embecta issued several material updates. On Mar 19, it agreed to acquire Owen Mumford for up to £150 million, adding drug-delivery capabilities. Earnings-related releases on Apr 21 and May 5 culminated in weak Q2 results and a sharply lower outlook, with the stock falling about 57.84%. The dividend announcement on May 5 coincided with that decline. Earlier, on Feb 11, board leadership changes had little price impact. Today’s conference participation fits into ongoing investor-relations efforts following these developments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
